Approval · Notice of Compliance 1022 · 2000
BAYCOL: Notice of Compliance 1022
Issued December 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1022
- Date
- December 28, 2000
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength; product monograph updated
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAYCOL | 02243223 | Cancelled Post Market |
Medicinal ingredients
- CERIVASTATIN 0.8 MG per TAB